| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3293730 | Gastroenterology | 2011 | 11 Pages |
Abstract
Extended analysis of the HALT-C cohort showed that long-term peginterferon therapy does not reduce the incidence of HCC among patients with advanced hepatitis C who did not achieve SVRs. Patients with cirrhosis who received peginterferon treatment had a lower risk of HCC than controls.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Anna S. Lok, James E. Everhart, Elizabeth C. Wright, Adrian M. Di Bisceglie, Hae-Young Kim, Richard K. Sterling, Gregory T. Everson, Karen L. Lindsay, William M. Lee, Herbert L. Bonkovsky, Jules L. Dienstag, Marc G. Ghany, Chihiro Morishima,